Home > Insider Trading > Filing (0000950170-24-106978)

Filing Details

Accession Number:: 0000950170-24-106978
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-09-16 20:51:38
Reporting Period:: 2024-09-16

Accepted Time:: 2024-09-16 20:51:38
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1953926	Zenas Biopharma Inc.	ZBIO	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1595117	Simeon George	985 Old Eagle School Road Suite 511 Wayne PA 19087		No	No	No	No
1853723	Sr One Capital Management, Llc	985 Old Eagle School Road Suite 511 Wayne PA 19087		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-09-16	1,505,388	$0.00	1,505,388	No	4	C	Indirect	See Note 2
Common Stock	Acquisiton	2024-09-16	441,176	$17.00	1,946,564	No	4	P	Indirect	See Note 2
Common Stock	Acquisiton	2024-09-16	501,796	$0.00	501,796	No	4	C	Indirect	See Note 3
Common Stock	Acquisiton	2024-09-16	1,352,942	$17.00	1,854,738	No	4	P	Indirect	See Note 3
Common Stock	Acquisiton	2024-09-16	669,061	$0.00	669,061	No	4	C	Indirect	See Note 4
Common Stock	Acquisiton	2024-09-16	441,176	$17.00	1,110,237	No	4	P	Indirect	See Note 4

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See Note 2
No	4	P	Indirect	See Note 2
No	4	C	Indirect	See Note 3
No	4	P	Indirect	See Note 3
No	4	C	Indirect	See Note 4
No	4	P	Indirect	See Note 4

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series C Convertible Preferred Stock	Disposition	2024-09-16	13,071,439	$0.00	1,505,388	$0.00
Common Stock	Series C Convertible Preferred Stock	Disposition	2024-09-16	4,357,146	$0.00	501,796	$0.00
Common Stock	Series C Convertible Preferred Stock	Disposition	2024-09-16	5,809,528	$0.00	669,061	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Footnotes

On September 16, 2024, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date.
The reported securities are held directly by SR One Capital Fund II Aggregator, LP. SR One Capital Partners II, LP is the general partner of SR One Capital Fund II Aggregator, LP, and SR One Capital Management, LLC is the general partner of SR One Capital Partners II, LP. Simeon George, M.D. is the managing member of SR One Capital Management, LLC. Each of SR One Capital Partners II, LP, SR One Capital Management, LLC and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.
The reported securities are held directly by AMZL, LP. SR One Capital SMA Partners, LP is the general partner of AMZL, LP, and SR One Capital Management, LLC is the general partner of SR One Capital SMA Partners, LP. Simeon George, M.D. is the managing member of SR One Capital Management, LLC. Each of SR One Capital SMA Partners, LP, SR One Capital Management, LLC and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.
The reported securities are held directly by SR One Capital Opportunities Fund I, LP. SR One Capital Opportunities Partners I, LP is the general partner of SR One Capital Opportunities Fund I, LP, and SR One Capital Management, LLC is the general partner of SR One Capital Opportunities Partners I, LP. Simeon George, M.D. is the managing member of SR One Capital Management, LLC. Each of SR One Capital Opportunities Partners I, LP, SR One Capital Management, LLC and Dr. George may be deemed to have shared power to vote or dispose of these shares, and each disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.